Home

Relay Therapeutics, Inc. - Common Stock (RLAY)

4.4700
-0.0700 (-1.54%)

Relay Therapeutics is a biotechnology company focused on transforming the drug discovery process through its innovative approach that combines advanced computational technologies and biophysics

The company specializes in developing precision medicines aimed at treating cancer and other serious diseases by designing therapeutics that specifically address the unique molecular features of patients' diseases. By leveraging its proprietary platform, Relay Therapeutics seeks to enhance the understanding of protein dynamics and interactions, enabling the identification of better drug candidates with improved efficacy and safety profiles.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is Relay Therapeutics, Inc. - Common Stock publicly traded?
Yes, Relay Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Relay Therapeutics, Inc. - Common Stock trade on?
Relay Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Relay Therapeutics, Inc. - Common Stock?
The ticker symbol for Relay Therapeutics, Inc. - Common Stock is RLAY on the Nasdaq Stock Market
What is the current price of Relay Therapeutics, Inc. - Common Stock?
The current price of Relay Therapeutics, Inc. - Common Stock is 4.470
When was Relay Therapeutics, Inc. - Common Stock last traded?
The last trade of Relay Therapeutics, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Relay Therapeutics, Inc. - Common Stock?
The market capitalization of Relay Therapeutics, Inc. - Common Stock is 543.61M
How many shares of Relay Therapeutics, Inc. - Common Stock are outstanding?
Relay Therapeutics, Inc. - Common Stock has 121.61M shares outstanding.